Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI Advisory Board
Benjamin Scirica MD
Benjamin Morgan Scirica MD Associate Editor
Douglas Zipes MD
Douglas P. Zipes MD Editor-in-Chief
See All Experts
featured
Published in Cardiology

Journal Scan / Research · August 11, 2015

Complete Revascularization in Patients With STEMI and Multivessel Disease Reduces Risk of Future Events

The Lancet

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Deepak Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI

The Lancet
Complete Revascularisation Versus Treatment of the Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease (DANAMI-3-PRIMULTI): An Open-Label, Randomised Controlled Trial
Lancet 2015 Aug 04;[EPub Ahead of Print], T Engstrøm, H Kelbæk, S Helqvist, DE Høfsten, L Kløvgaard, L Holmvang, E Jørgensen, F Pedersen, K Saunamäki, P Clemmensen, O De Backer, J Ravkilde, H-H Tilsted, AB Villadsen, J Aarøe, SE Jensen, B Raungaard, L Køber

Further Reading

Most Read This Week

Recently Updated